Abstract
Some new oleic acid, linoleic acid, lauric acid derivatives of 5-aminosalicylic acid were produced in order to enhance bioactivity properties of 5-aminosalicylic acid. All new compounds’ structures were confirmed by spectroscopic methods. Moreover, in vitro antibacterial, anticancer, and anti-inflammatory activities of new synthesized compounds were investigated. Antibacterial activity was studied against pathogenic Gram-negative bacteria, Escherichia coli and Gram-positive bacteria, Staphylococcus aureus via disc diffusion method. Additionally, all derivatives’ anti-inflammatory activity were evaluated through NO suppression assay using interferon gamma (IFN-γ)/lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. Furthermore, in vitro cytotoxicity assay was probed using MTT test against 3T3 and HT-29 cell lines. In another effort, docking studies were performed to predict the possible interactions and binding energy of new compounds against cyclooxygenase (COX-1/COX-2) and lipoxygenase (5-LOX) proteins. In conclusion, all new compounds exhibited moderate to better bioactivity improvements in comparison with parent drug. Also study of interactions between the new derivatives with active sites of proteins presented greater binding affinities than 5-aminosalicylic acid.
Graphical abstract
Similar content being viewed by others
References
Giannini E, Kane S, Testa R, Savarino V (2005) Dig Liver Dis 37:723
Friend DR (2005) Adv Drug Delivery Rev 57:247
Williams C, Panaccione R, Ghosh S, Rioux K (2011) Therap Adv Gastroenterol 4:237
Stolfi C, Fina D, Caruso R, Caprioli F, Sarra M, Fantini MC, Rizzo A, Pallone F, Monteleone G (2008) Biochem Pharmacol 75:668
Tursi A, Joseph RE, Streck P (2011) Dig Dis Sci 56:3112
Campregher C, Luciani MG, Biesenbach P, Evstatiev R, Lyakhovich A, Gasche C (2010) Inflamm Bowel Dis 16:576
Couto D, Ribeiro D, Freitas M, Gomes A, Lima JL, Fernandes E (2010) Redox Rep 15:259
Freeman HJ (2012) Clin Med Insights Gastroenterol 5:77
Yang Z, Ye X, Wu Q, Wu K, Fan D (2014) Int J Surg 12:516
Travis S, Jewell D (1994) Pharmacol Ther 63:135
Soliman MH, Mohamed GG (2013) Spectrochim Acta A Mol Biomol Spectrosc 107:8
RajeshYadav O (2011) J Pharm Sci Res 3:966
Babazadeh M, Edjlali L, Rashidian L (2007) J Polym Res 14:207
Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A (2007) J Control Release 123:211
Jung YJ, Lee JS, Kim YM (2001) J Pharm Sci 90:1767
Williams CM (2000) Ann Zootech 49:165
Field CJ, Blewett HH, Proctor S, Vine D (2009) Appl Physiol Nutr Metab 34:979
Adnani A, Basri M, Chaibakhsh N, Ahangar HA, Salleh AB, Rahman RNZRA, Rahman MBA (2011) Carbohydr Res 346:472
Zhu Y-P, Su Z-W, Li C-H (1989) J Natl Cancer Inst 81:1302
Benjamin S, Spener F (2009) Nutr Metab 6:36
Fitscher B, Elsing C, Riedel H-D, Gorski J, Stremmel W (1996) Exp Biol Med 212:15
Waterman E, Lockwood B (2007) Altern Med Rev 12:331
Singh S, Taneja M, Majumdar DK (2007) Indian J Exp Biol 45:403
Kitahara T, Koyama N, Matsuda J, Aoyama Y, Hirakata Y, Kamihira S, Kohno S, Nakashima M, Sasaki H (2004) Biol Pharm Bull 27:1321
Roynette CE, Calder PC, Dupertuis YM, Pichard C (2004) Clin Nutr 23:139
Gil A (2002) Biomed Pharmacother 56:388
Mellou F, Loutrari H, Stamatis H, Roussos C, Kolisis FN (2006) Process Biochem 41:2029
Singh S, Nair V, Jain S, Gupta Y (2008) Indian J Exp Biol 46:453
Calder PC (2006) Am J Clin Nutr 83:S1505
Pinto TA, Hrdina R, Kirsch G, Campos AM, Rodrigues LM, Esteves AP (2012) Arkivoc 6:185
Jiang Y, Kuang C (2009) J Chem Sci (Bangalore, India) 121:1035
Desbois AP, Mearns-Spragg A, Smith VJ (2009) Mar Biotechnol 11:45
Campbell JW, Cronan JE Jr (2001) Annu Rev Microbiol 55:305
Hendriksen R, Agenaar J, Van Bergen M (2003) Laboratory protocols. Isolation of Salmonella. http://www.antimicrobialresistance.dk/data/images/salmonella2_pdf.pdf
Kowti R, Harsha R, Ahmed M, Hareesh A, Thammanna Gowda S, Dinesha R, Kumar BS, Ali MI (2010) Res J Pharm Biol Chem Sci 3:691
Leong SW, Faudzi SMM, Abas F, Aluwi MFFM, Rullah K, Wai LK, Bahari MNA, Ahmad S, Tham CL, Shaari K (2014) Molecules 19:16058
Ali NM, Mohd Yusof H, Yeap S-K, Ho W-Y, Beh B-K, Long K, Koh S-P, Abdullah MP, Alitheen NB (2014) Evid Based Complement Alternat Med 2014:6
Mosmann T (1983) J Immunol Methods 65:55
Boncler M, Różalski M, Krajewska U, Podsędek A, Watala C (2014) J Pharmacol Toxicol Methods 69:9
Vareed SK, Reddy MK, Schutzki RE, Nair MG (2006) Life Sci 78:777
Charlier C, Michaux C (2003) Eur J Med Chem 38:645
Palkar MB, Singhai AS, Ronad PM, Vishwanathswamy A, Boreddy TS, Veerapur VP, Shaikh MS, Rane RA, Karpoormath R (2014) Bioorg Med Chem 22:2855
Hegazy GH, Ali HI (2012) Bioorg Med Chem 20:1259
Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, Brash AR, Newcomer ME (2011) Science 331:217
Wallace AC, Laskowski RA, Thornton JM (1995) Protein Eng 8:127
Acknowledgments
We are grateful for financial support of this work by ERGS (KPM) with Grant No. 5527054 and University of Putra Malaysia (UPM).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yousefi, S., Bayat, S., Rahman, M.B.A. et al. Synthesis, bioactivity evaluation, and docking study of 5-aminosalicylic acid’s fatty acid derivatives. Monatsh Chem 146, 2139–2149 (2015). https://doi.org/10.1007/s00706-015-1538-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-015-1538-0